1. Gardner RV. Sickle cell disease: advances in treatment. Ochsner J. 2018;18(4):377–89.
2. Kato GJ, Piel FB, Reid CD, et al. Sickle cell disease. Nat Rev Dis Primers. 2018. https://doi.org/10.1038/nrdp.2018.10.
3. Global Blood Therapeutics. Global Blood Therapeutics announces GBT440 receives FDA fast track designation for sickle cell disease [media release]. 12 Oct 2015. http://www.globalbloodtx.com.
4. Global Blood Therapeutics. Global Blood Therapeutics receives FDA orphan drug designation for GBT440 in sickle cell disease [media release]. 31 Dec 2015. http://www.globalbloodtx.com.
5. Global Blood Therapeutics. Global Blood Therapeutics receives rare pediatric disease designation from FDA for GBT440 for treatment of sickle cell disease (SCD) [media release]. 5 Sep 2017. http://www.globalbloodtx.com.